The clinical laboratory sector stands at a critical juncture, navigating what industry analysts describe as a "perfect storm" of converging…
Read More
Eli Lilly’s Foundayo Secures FDA Approval, Challenging Novo Nordisk’s Oral Obesity Drug Dominance
The United States Food and Drug Administration (FDA) has granted approval to Eli Lilly and Company’s novel oral glucagon-like peptide-1…
Read More
Science News: A Century of Empowering Public Understanding of Science, Medicine, and Technology
Founded in 1921 with the singular purpose of disseminating accurate and accessible information about scientific advancements, Science News has evolved…
Read More
The Rise of AI Agent Skill Marketplaces: A New Frontier in Autonomous AI Development and Deployment.
The landscape of artificial intelligence is undergoing a profound transformation, moving rapidly beyond the foundational large language models and simple…
Read More
Coordinated Molecular and Physiological Adaptations Enable Activity at Subfreezing Temperatures in the Snow Fly Chionea alexandriana
In the stark, frozen landscapes of winter, where most life retreats into dormancy or succumbs to the biting cold, a…
Read More
TWiV 1288: Clinical update with Dr. Daniel Griffin
In a recent episode of the highly regarded scientific podcast "This Week in Virology" (TWiV), host Vincent Racaniello and clinical…
Read More
The hidden evolution making men’s sperm more dangerous with age
The biological mechanisms governing human inheritance have long been understood through the lens of random genetic drift and environmental influence,…
Read More
Lilly is now the top pharma company by revenue as Mounjaro (+99%) and Zepbound (+175%) combine for $36.5B in FY2025
Eli Lilly and Company has officially ascended to the pinnacle of the global pharmaceutical industry, concluding fiscal year 2025 as…
Read More
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.
The Centers for Medicare and Medicaid Services (CMS) has initiated a critical dialogue with the clinical laboratory community, seeking direct…
Read More
Telomir Pharmaceuticals Submits Investigational New Drug Application for Telomir-1 to FDA for Advanced Triple-Negative Breast Cancer
Telomir Pharmaceuticals has taken a significant stride in its mission to combat advanced and metastatic triple-negative breast cancer (TNBC) by…
Read More
